|
1
|
Rom S and Persidsky Y: Cannabinoid
receptor 2: Potential role in immunomodulation and
neuroinflammation. J Neuroimmune Pharmacol. 8:608–620. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zogopoulos P, Vasileiou I, Patsouris E and
Theocharis SE: The role of endocannabinoids in pain modulation.
Fundam Clin Pharmacol. 27:64–80. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Witkamp R and Meijerink J: The
endocannabinoid system: An emerging key player in inflammation.
Curr Opin Clin Nutr Metab Care. 17:130–138. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bátkai S, Osei-Hyiaman D, Pan H, El-Assal
O, Rajesh M, Mukhopadhyay P, Hong F, Harvey-White J, Jafri A, Haskó
G, et al: Cannabinoid-2 receptor mediates protection against
hepatic ischemia/reperfusion injury. FASEB J. 21:1788–1800. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Núñez E, Benito C, Pazos MR, Barbachano A,
Fajardo O, González S, Tolón RM and Romero J: Cannabinoid CB2
receptors are expressed by perivascular microglial cells in the
human brain: an immunohistochemical study. Synapse. 53:208–213.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yao BB, Hsieh G, Daza AV, Fan Y, Grayson
GK, Garrison TR, El Kouhen O, Hooker BA, Pai M, Wensink EJ, et al:
Characterization of a cannabinoid CB2 receptor-selective agonist,
A-836339 [2,2,3,3-tetramethyl-cyclopropanecarboxylic acid
[3-(2-methoxy-ethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]-amide],
using in vitro pharmacological assays, in vivo pain models, and
pharmacological magnetic resonance imaging. J Pharmacol Exp Ther.
328:141–151. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Marques TH, Marques ML, Medeiros JV, Silva
RO, dos Reis Barbosa AL, Lima TC, de Sousa DP and de Freitas RM:
Cyane-carvone, a synthetic derivative of carvone, inhibits
inflammatory response by reducing cytokine production and oxidative
stress and shows antinociceptive effect in mice. Inflammation.
37:966–977. 2014.PubMed/NCBI
|
|
8
|
Albayrak A, Halici Z, Cadirci E, Polat B,
Karakus E, Bayir Y, Unal D, Atasoy M and Dogrul A: Inflammation and
peripheral 5-HT7 receptors: The role of 5-HT7 receptors in
carrageenan induced inflammation in rats. Eur J Pharmacol.
715:270–279. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Büyükokuroğlu ME: Anti-inflammatory and
antinociceptive properties of dantrolene sodium in rats and mice.
Pharmacol Res. 45:455–460. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Uzkeser H, Cadirci E, Halici Z, Odabasoglu
F, Polat B, Yuksel TN, Ozaltin S and Atalay F: Anti-inflammatory
and antinociceptive effects of salbutamol on acute and chronic
models of inflammation in rats: Involvement of an antioxidant
mechanism. Mediators Inflamm. 2012:4389122012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Conti S, Costa B, Colleoni M, Parolaro D
and Giagnoni G: Antiinflammatory action of endocannabinoid
palmitoylethanolamide and the synthetic cannabinoid nabilone in a
model of acute inflammation in the rat. Br J Pharmacol.
135:181–187. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Iwamura H, Suzuki H, Ueda Y, Kaya T and
Inaba T: In Vitro and in vivo pharmacological characterization of
JTE- 907, a novel selective ligand for cannabinoid CB 2 receptor. J
Pharmacol Exp Ther. 296:420–425. 2001.PubMed/NCBI
|
|
13
|
Ghosh S, Wise LE, Chen Y, Gujjar R,
Mahadevan A, Cravatt BF and Lichtman AH: The monoacylglycerol
lipase inhibitor JZL184 suppresses inflammatory pain in the mouse
carrageenan model. Life Sci. 92:498–505. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Comelli F, Giagnoni G, Bettoni I, Colleoni
M and Costa B: The inhibition of monoacylglycerol lipase by URB602
showed an anti-inflammatory and anti-nociceptive effect in a murine
model of acute inflammation. Br J Pharmacol. 152:787–794. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lunn CA, Fine JS, Rojas-Triana A, Jackson
JV, Fan X, Kung TT, Gonsiorek W, Schwarz MA, Lavey B, Kozlowski JA,
et al: A novel cannabinoid peripheral cannabinoid
receptor-selective inverse agonist blocks leukocyte recruitment in
vivo. J Pharmacol Exp Ther. 316:780–788. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rivers-Auty JR, Smith PF and Ashton JC:
The cannabinoid CB2receptor agonist GW405833 does not ameliorate
brain damage induced by hypoxia-ischemia in rats. Neurosci Lett.
569:104–109. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hayakawa K, Mishima K, Nozako M, Hazekawa
M, Irie K, Fujioka M, Orito K, Abe K, Hasebe N, Egashira N, et al:
Delayed treatment with cannabidiol has a cerebroprotective action
via a cannabinoid receptor-independent myeloperoxidase-inhibiting
mechanism. J Neurochem. 102:1488–1496. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Casini AF, Ferrali M, Pompella A, Maellaro
E and Comporti M: Lipid peroxidation and cellular damage in
extrahepatic tissues of bromobenzene-intoxicated mice. Am J Pathol.
123:520–531. 1986.PubMed/NCBI
|
|
19
|
Sedlak J and Lindsay RH: Estimation of
total, protein-bound, and nonprotein sulfhydryl groups in tissue
with Ellman's reagent. Anal Biochem. 25:192–205. 1968. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bradley PP, Priebat DA, Christensen RD and
Rothstein G: Measurement of cutaneous inflammation: Estimation of
neutrophil content with an enzyme marker. J Invest Dermatol.
78:206–209. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Arslan SO, Gelir E, Sayan H and Ozacmak
VH: L-Arginine and melatonin interaction in rat intestinal
ischemia-reperfusion. Fundam Clin Pharmacol. 19:533–535. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Arslan SO: Morphine modulates
microvascular leakage dose-dependently in the airway of
ovalbumin-sensitized rats. Turk J Med Sci. 40:279–286. 2010.
|
|
23
|
Ashton JC and Glass M: The cannabinoid CB2
receptor as a target for inflammation-dependent neurodegeneration.
Curr Neuropharmacol. 5:73–80. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Berger ND, Gadotti VM, Petrov RR, Chapman
K, Diaz P and Zamponi GW: NMP-7 inhibits chronic inflammatory and
neuropathic pain via block of Cav3.2 T-type calcium channels and
activation of CB2 receptors. Mol Pain. 10:772014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Elmes SJ, Winyard LA, Medhurst SJ, Clayton
NM, Wilson AW, Kendall DA and Chapman V: Activation of CB1 and CB2
receptors attenuates the induction and maintenance of inflammatory
pain in the rat. Pain. 118:327–335. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Valenzano KJ, Tafesse L, Lee G, Harrison
JE, Boulet JM, Gottshall SL, Mark L, Pearson MS, Miller W, Shan S,
et al: Pharmacological and pharmacokinetic characterization of the
cannabinoid receptor 2 agonist, GW405833, utilizing rodent models
of acute and chronic pain, anxiety, ataxia and catalepsy.
Neuropharmacology. 48:658–672. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Harvey BS, Nicotra LL, Vu M and Smid SD:
Cannabinoid CB2 receptor activation attenuates cytokine-evoked
mucosal damage in a human colonic explant model without changing
epithelial permeability. Cytokine. 63:209–217. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tambaro S, Antonietta M, Mastinu A and
Lazzari P: Evaluation of selective cannabinoid CB(1) and CB(2)
receptor agonists in a mouse model of lipopolysaccharide-induced
interstitial cystitis. Eur J Pharmacol. Elsevier. 729:67–74.
2014.
|
|
29
|
Yang YY, Hsieh SL, Lee PC, Yeh YC, Lee KC,
Hsieh YC, Wang YW, Lee TY, Huang YH, Chan CC and Lin HC: Long-term
cannabinoid type 2 receptor agonist therapy decreases bacterial
translocation in rats with cirrhosis and ascites. J Hepatol.
61:1004–1013. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Smoum R, Baraghithy S, Chourasia M, Breuer
A, Mussai N, Attar-Namdar M, Kogan NM, Raphael B, Bolognini D,
Cascio MG, et al: CB2 cannabinoid receptor agonist enantiomers
HU-433 and HU-308: An inverse relationship between binding affinity
and biological potency. Proc Natl Acad Sci USA. 112:8774–8779.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Alhouayek M, Lambert DM, Delzenne NM, Cani
PD and Muccioli GG: Increasing endogenous 2-arachidonoylglycerol
levels counteracts colitis and related systemic inflammation. FASEB
J. 25:2711–2721. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Pasquarelli N, Porazik C, Hanselmann J,
Weydt P, Ferger B and Witting A: Comparative biochemical
characterization of the monoacylglycerol lipase inhibitor KML29 in
brain, spinal cord, liver, spleen, fat and muscle tissue.
Neuropharmacology. 91:148–156. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wise LE, Cannavacciulo R, Cravatt BF,
Martin BF and Lichtman AH: Evaluation of fatty acid amides in the
carrageenan-induced paw edema model. Neuropharmacology. 54:181–188.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Haruna T, Soga M, Morioka Y, Imura K,
Furue Y, Yamamoto M, Hayakawa J, Deguchi M, Arimura A and Yasui K:
The inhibitory effect of S-777469, a cannabinoid type 2 receptor
agonist, on skin inflammation in mice. Pharmacology. 99:259–267.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang J and Chen C: Endocannabinoid
2-arachidonoylglycerol protects neurons by limiting COX-2
elevation. J Biol Chem. 283:22601–22611. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kim J and Watkins BA: Cannabinoid receptor
antagonists and fatty acids alter endocannabinoid system gene
expression and COX activity. J Nutr Biochem. 25:815–823. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liu YJ, Fan HB, Jin Y, Ren CG, Jia XE,
Wang L, Chen Y, Dong M, Zhu KY, Dong ZW, et al: Cannabinoid
receptor 2 suppresses leukocyte inflammatory migration by
modulating the JNK/c-Jun/Alox5 pathway. J Biol Chem.
288:13551–13562. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Nussbaum C, Klinke A, Adam M, Baldus S and
Sperandio M: Myeloperoxidase: A leukocyte-derived protagonist of
inflammation and cardiovascular disease. Antioxid Redox Signal.
18:692–713. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Winterbourn CC, Kettle AJ and Hampton MB:
Reactive oxygen species and neutrophil function. Annu Rev Biochem.
85:765–1092. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Michler T, Storr M, Kramer J, Ochs S, Malo
A, Reu S, Göke B and Schäfer C: Activation of cannabinoid receptor
2 reduces inflammation in acute experimental pancreatitis via
intra-acinar activation of p38 and MK2-dependent mechanisms. Am J
Physiol Gastrointest Liver Physiol. 304:G181–G192. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Neri M, Fineschi V, Di Paolo M, Pomara C,
Riezzo I, Turillazzi E and Cerretani D: Cardiac oxidative stress
and inflammatory cytokines response after myocardial infarction.
Curr Vasc Pharmacol. 13:26–36. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Li YY, Li YN, Ni JB, Chen CJ, Lv S, Chai
SY, Wu RH, Yüce B and Storr M: Involvement of cannabinoid-1 and
cannabinoid-2 receptors in septic ileus. Neurogastroenterol Motil.
22:e350–e388. 2010. View Article : Google Scholar
|
|
43
|
Silva RO, Sousa FB, Damasceno SR, Carvalho
NS, Silva VG, Oliveira FR, Sousa DP, Aragão KS, Barbosa AL, Freitas
RM and Medeiros JV: Phytol, a diterpene alcohol, inhibits the
inflammatory response by reducing cytokine production and oxidative
stress. Fundam Clin Pharmacol. 28:455–464. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Gui H, Tong Q, Qu W, Mao CM and Dai SM:
The endocannabinoid system and its therapeutic implications in
rheumatoid arthritis. Int Immunopharmacol. 26:86–91. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Arslan SO, Zerin M, Vural H and Coskun A:
The effect of melatonin on bleomycin-induced pulmonary fibrosis in
rats. J Pineal Res. 32:21–25. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Gui H, Sun Y, Luo ZM, Su DF, Dai SM and
Liu X: Cannabinoid receptor 2 protects against acute experimental
sepsis in mice. Mediators Inflamm. 2013:7413032013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Schuelert N, Zhang C, Mogg AJ, Broad LM,
Hepburn DL, Nisenbaum ES, Johnson MP and McDougall JJ: Paradoxical
effects of the cannabinoid CB2 receptor agonist GW405833 on rat
osteoarthritic knee joint pain. Osteoarthr Cartil. 18:1536–1543.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Whiteside GT, Gottshall SL, Boulet JM,
Chaffer SM, Harrison JE, Pearson MS, Turchin PI, Mark L, Garrison
AE and Valenzano KJ: A role for cannabinoid receptors, but not
endogenous opioids, in the antinociceptive activity of the
CB2-selective agonist, GW405833. Eur J Pharmacol. 528:65–72. 2005.
View Article : Google Scholar : PubMed/NCBI
|
